Nothing about us without us is a centuries-old value that is a cornerstone of meaningful patient engagement in clinical research. Such engagement has not been automatic and is still largely absent in geriatric oncology research, where older patients traditionally have been excluded from clinical trials, and consideration has not been given to the inclusion of similar patients as partners in the research. There’s been progress in the past couple of decades, but there is still a long way to go to realize the full potential of patient engagement in clinical research: to make it standard research practice.

Resistance training can provide many benefits, including increased muscle mass; decreased adipose tissue; and improved metabolism, bone density, strength, and mobility. However, data are limited on the association between resistance training and the development or exacerbation of lymphedema, a common and potentially debilitating consequence of breast cancer treatment. In a recent study reported in JAMA Network Open, Shamsesfandabadi et al examined the association between resistance training and lymphedema among breast cancer survivors.

In a German population–based, matched case-control study reported in the Journal of Clinical Oncology, Wankhede et al found that type 2 diabetes (T2D) may be associated with colorectal cancer (CRC) risk and survival according to tumor immunity status.

The American Cancer Society (ACS) and its advocacy affiliate the American Cancer Society Cancer Action Network (ACS CAN) have announced Shane Jacobson as their Chief Executive Officer, effective August 12, 2025. He steps into the role following Wayne A.I. Frederick, MD, MBA, FACS, who has served as interim Chief Executive Officer of both organizations since November 2024.